Articles published by KalVista Pharmaceuticals, Inc.
![](https://mms.businesswire.com/media/20220603005061/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220601005449/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220526005154/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220517005285/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220411005126/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference
April 11, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220404005265/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220322005365/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Announces Publication of Additional KVD900 Data in Clinical & Experimental Allergy
March 22, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220203005024/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220202005269/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals to Present Data on Oral On-Demand HAE Therapy KVD900 at AAAAI 2022
February 02, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220202005184/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20220124005023/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20220104005254/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 04, 2022
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20211209005081/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
December 09, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20211203005047/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20211110005425/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20211109005252/en/924580/5/3459551_Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
November 09, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20211108005569/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20211104005306/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 04, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20211004005869/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210921005099/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals to Present at Cantor Virtual Global Healthcare Conference
September 21, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210914005158/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Announces the Lifting of FDA Clinical Hold for Phase 2 Trial of KVD824
September 14, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210909005203/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports First Fiscal Quarter Results
September 09, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210902005841/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210823005130/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20210809005130/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 09, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210713005347/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
July 13, 2021
Via Business Wire
Tickers
KALV
![](https://mms.businesswire.com/media/20210712005213/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20210628005222/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20210605005033/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20210527005025/en/670569/5/Kalvista-Logo-Final-01.jpg)
Via Business Wire
Tickers
KALV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.